title: Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: added value or an anachronism?
authors.forename: Diane L
authors.initials: DL
authors.lastname: Reidy-Lagunes
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Gollub
authors.forename: Leonard B
authors.initials: LB
authors.lastname: Saltz
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000000981:diagnostic imaging; D015282:Octreotide; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D015282:Octreotide